182 related articles for article (PubMed ID: 9878042)
1. Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturation.
Peng T; Orsborn KI; Orbach MJ; Galgiani JN
J Infect Dis; 1999 Feb; 179(2):518-21. PubMed ID: 9878042
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
4. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice.
Peng T; Shubitz L; Simons J; Perrill R; Orsborn KI; Galgiani JN
Infect Immun; 2002 Jul; 70(7):3330-5. PubMed ID: 12065470
[TBL] [Abstract][Full Text] [Related]
5. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
Silva AJ; Benitez JA
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
[TBL] [Abstract][Full Text] [Related]
6. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
Jiang C; Magee DM; Ivey FD; Cox RA
Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
[TBL] [Abstract][Full Text] [Related]
7. Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential.
Dugger KO; Villareal KM; Ngyuen A; Zimmermann CR; Law JH; Galgiani JN
Biochem Biophys Res Commun; 1996 Jan; 218(2):485-9. PubMed ID: 8561782
[TBL] [Abstract][Full Text] [Related]
8. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.
Kirkland TN; Finley F; Orsborn KI; Galgiani JN
Infect Immun; 1998 Aug; 66(8):3519-22. PubMed ID: 9673228
[TBL] [Abstract][Full Text] [Related]
10. Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis.
Silva AJ; Mohan A; Benitez JA
Vaccine; 2003 Dec; 21(32):4715-21. PubMed ID: 14585681
[TBL] [Abstract][Full Text] [Related]
11. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii 1,2-alpha-mannosidase identified in the coccidioidal T27K vaccine by immunoproteomic methods.
Lunetta JM; Simmons KA; Johnson SM; Pappagianis D
Ann N Y Acad Sci; 2007 Sep; 1111():164-80. PubMed ID: 17363438
[TBL] [Abstract][Full Text] [Related]
13. Positive directional selection in the proline-rich antigen (PRA) gene among the human pathogenic fungi Coccidioides immitis, C. posadasii and their closest relatives.
Johannesson H; Vidal P; Guarro J; Herr RA; Cole GT; Taylor JW
Mol Biol Evol; 2004 Jun; 21(6):1134-45. PubMed ID: 15034131
[TBL] [Abstract][Full Text] [Related]
14. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
Jiang C; Magee DM; Quitugua TN; Cox RA
Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
[TBL] [Abstract][Full Text] [Related]
15. Attributes of deficient immunity in mice receiving Coccidioides immitis Spherule vaccine by the intravenous route.
Scalarone GM; Levine HB
Sabouraudia; 1969 Oct; 7(3):169-77. PubMed ID: 5385153
[No Abstract] [Full Text] [Related]
16. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
Fierer J; Waters C; Walls L
J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
[TBL] [Abstract][Full Text] [Related]
17. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
19. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
Pappagianis D
Fungal Genet Biol; 2001 Feb; 32(1):1-9. PubMed ID: 11277621
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii Cu,Zn superoxide dismutase identified by proteomic analysis of the coccidioidal T27K vaccine.
Lunetta JM; Simmons KA; Johnson SM; Pappagianis D
Ann N Y Acad Sci; 2007 Sep; 1111():181-97. PubMed ID: 17344523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
